Free Trial

Innate Pharma (IPHA) Short Interest Ratio & Short Volume

Innate Pharma logo
$1.88
-0.02 (-1.06%)
(As of 11/1/2024 ET)

Innate Pharma Short Interest Data

Innate Pharma (IPHA) has a short interest of 58,800 shares. This marks a -18.11% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.4, indicating that it would take 7.4 days of the average trading volume of 9,202 shares to cover all short positions.

Current Short Interest
58,800 shares
Previous Short Interest
71,800 shares
Change Vs. Previous Month
-18.11%
Dollar Volume Sold Short
$119,364.00
Short Interest Ratio
7.4 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
80,970,000 shares
Percentage of Shares Shorted
0.07%
Today's Trading Volume
6,627 shares
Average Trading Volume
9,202 shares
Today's Volume Vs. Average
72%
Short Selling Innate Pharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Innate Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

IPHA Short Interest Over Time

IPHA Days to Cover Over Time

IPHA Percentage of Float Shorted Over Time

Innate Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202458,800 shares $119,364.00 -18.1%N/A7.4 $2.03
9/30/202471,800 shares $164,422.00 +20.3%N/A10 $2.29
9/15/202459,700 shares $134,922.00 -8.3%N/A9 $2.26
8/31/202465,100 shares $149,404.50 -2.5%N/A9.3 $2.30
8/15/202466,800 shares $150,300.00 +3.6%N/A8.1 $2.25
7/31/202464,500 shares $138,352.50 -11.5%N/A7.8 $2.15
7/15/202472,900 shares $154,548.00 +5.2%N/A9.1 $2.12
6/30/202469,300 shares $134,442.00 -4.9%N/A7.7 $1.94
6/15/202472,900 shares $171,315.00 +4.1%N/A7 $2.35
5/31/202470,000 shares $191,800.00 -0.3%N/A6.7 $2.74
5/15/202470,200 shares $175,942.26 -11.3%N/A7.2 $2.51
4/30/202479,100 shares $182,721.00 -2.7%N/A8.8 $2.31
4/15/202481,300 shares $196,746.00 +5.7%N/A7.8 $2.42
3/31/202476,900 shares $221,472.00 -13.7%N/A7.7 $2.88
3/15/202489,100 shares $217,404.00 +13.7%N/A7.6 $2.44
2/29/202478,400 shares $205,408.00 -4.9%N/A4.1 $2.62
2/15/202482,400 shares $212,592.00 +8.4%N/A4.7 $2.58
1/31/202476,000 shares $203,680.00 -0.9%N/A4 $2.68
1/15/202476,700 shares $214,760.00 -8.9%N/A3.7 $2.80
12/31/202384,200 shares $235,760.00 +55.9%N/A3.9 $2.80
12/15/202354,000 shares $130,140.00 -5.9%N/A2.6 $2.41
11/30/202357,400 shares $137,760.00 -4.3%N/A4.3 $2.40
11/15/202360,000 shares $147,600.00 -6.0%N/A4.2 $2.46
10/31/202363,800 shares $151,844.00 +11.5%N/A4.4 $2.38
10/15/202357,200 shares $132,418.00 -8.5%N/A5 $2.32
9/30/202362,500 shares $158,125.00 -3.4%N/A6 $2.53
9/15/202364,700 shares $192,159.00 -1.5%N/A6.7 $2.97
8/31/202365,700 shares $191,324.97 -8.1%N/A5.2 $2.91
8/15/202371,500 shares $206,635.00 -3.8%N/A6.1 $2.89
7/31/202374,300 shares $218,442.00 -1.9%N/A6.8 $2.94
7/15/202375,700 shares $244,511.00 -3.8%N/A6.4 $3.23
6/30/202378,700 shares $242,002.50 +20.0%N/A6.1 $3.08
6/15/202365,600 shares $213,856.00 +9.7%N/A4 $3.26
5/31/202359,800 shares $175,812.00 -4.3%N/A3.8 $2.94
5/15/202362,500 shares $186,875.00 No ChangeN/A3.6 $2.99
10/31/2022147,600 shares $317,340.00 +12.8%N/A12.9 $2.15
10/15/2022130,900 shares $261,800.00 +15.5%N/A12.5 $2.00
9/30/2022113,300 shares $226,600.00 +1.3%N/A12.7 $2.00
9/15/2022111,900 shares $284,226.00 +2.3%N/A13.3 $2.54
8/31/2022109,400 shares $293,192.00 +0.2%N/A6.4 $2.68
True paradigm shift (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

8/15/2022109,200 shares $321,048.00 -10.1%N/A5.9 $2.94
7/31/2022121,500 shares $388,787.85 -3.6%N/A6.1 $3.20
7/15/2022126,000 shares $347,760.00 +0.3%N/A4.9 $2.76
6/30/2022125,600 shares $339,120.00 +3.9%N/A4.8 $2.70
6/15/2022120,900 shares $305,877.00 +1.9%N/A4.6 $2.53
5/31/2022118,700 shares $315,742.00 -13.6%N/A6.2 $2.66
5/15/2022137,300 shares $394,051.00 +8.0%N/A6.7 $2.87
4/30/2022127,100 shares $364,777.00 -9.3%N/A5.7 $2.87
4/15/2022140,100 shares $438,513.00 +4.0%N/A6 $3.13
3/31/2022134,700 shares $452,592.00 +105.0%N/A5.3 $3.36
3/15/202265,700 shares $207,612.00 +13.9%N/A1.6 $3.16
2/28/202257,700 shares $196,757.00 -2.5%N/A1 $3.41
2/15/202259,200 shares $219,632.00 -15.6%N/A0.9 $3.71
1/31/202270,100 shares $265,679.00 -15.3%N/A1 $3.79
1/15/202282,800 shares $375,084.00 -22.3%N/A1.1 $4.53
12/31/2021106,600 shares $486,096.00 +247.2%N/A1.3 $4.56
12/15/202130,700 shares $158,105.00 +0.3%N/A0.3 $5.15
11/30/202130,600 shares $151,776.00 -39.8%N/A0 $4.96
11/15/202150,800 shares $263,652.00 +195.4%N/A0 $5.19
10/29/202117,200 shares $99,760.00 +18.6%N/A0 $5.80
10/15/202114,500 shares $85,115.00 -89.5%N/A0 $5.87
9/30/2021137,800 shares $850,226.00 +79.7%N/A0.1 $6.17
9/15/202176,700 shares $427,986.00 +2,456.7%N/A0 $5.58
8/31/20213,000 shares $10,920.00 -45.5%N/A0 $3.64
8/13/20215,500 shares $18,700.00 -35.3%N/A0.3 $3.40
7/30/20218,500 shares $28,220.00 -33.6%N/A0.5 $3.32
7/15/202112,800 shares $41,472.00 +100.0%N/A0.7 $3.24
6/30/20216,400 shares $21,056.00 -61.0%N/A0.4 $3.29
6/15/202116,400 shares $65,764.00 +1,161.5%N/A1.1 $4.01
5/28/20211,300 shares $5,083.00 +225.0%N/A0.1 $3.91
5/14/2021400 shares $1,580.00 -81.8%N/A0 $3.95
4/30/20212,200 shares $9,416.00 -29.0%N/A0.1 $4.28
4/15/20213,100 shares $13,578.00 -55.7%N/A0 $4.38
3/31/20217,000 shares $30,030.00 -6.7%N/A0.2 $4.29
3/15/20217,500 shares $34,275.00 +53.1%N/A0.2 $4.57
2/26/20214,900 shares $21,658.00 -27.9%N/A0.1 $4.42
2/12/20216,800 shares $30,804.00 +385.7%N/A0.2 $4.53
1/29/20211,400 shares $5,740.00 -74.1%N/A0 $4.10
1/15/20215,400 shares $24,516.00 -77.2%N/A0.2 $4.54
12/31/202023,700 shares $102,147.00 -52.5%N/A0.9 $4.31
12/15/202049,900 shares $219,061.00 +91.2%N/A2.5 $4.39
11/30/202026,100 shares $145,116.00 -7.1%N/A1.5 $5.56
11/15/202028,100 shares $133,475.00 -23.2%N/A1.6 $4.75
10/30/202036,600 shares $146,217.00 +21.6%N/A2.5 $4.00
10/15/202030,100 shares $121,002.00 +32.6%N/A2.5 $4.02
9/30/202022,700 shares $87,168.00 -22.5%N/A2.2 $3.84
9/15/202029,300 shares $127,455.00 +70.4%N/A2.9 $4.35
8/31/202017,200 shares $106,812.00 -5.5%N/A2.2 $6.21
8/14/202018,200 shares $119,210.00 -40.9%N/A2.3 $6.55
7/31/202030,800 shares $187,205.48 +76.0%N/A3.3 $6.08
This is treason (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

7/15/202017,500 shares $105,175.00 +25.9%N/A2.1 $6.01
6/30/202013,900 shares $88,404.00 -0.7%N/A1.7 $6.36
6/15/202014,000 shares $87,780.00 -23.1%N/A1.4 $6.27
5/29/202018,200 shares $121,030.00 -59.4%N/A1.3 $6.65
5/15/202044,800 shares $300,160.00 +44.5%N/A2.7 $6.70
4/30/202031,000 shares $235,600.00 -13.9%N/A1.9 $7.60
4/15/202036,000 shares $251,100.00 -15.3%N/A2.3 $6.98
3/31/202042,500 shares $320,875.00 -29.9%N/A2.1 $7.55
3/13/202060,600 shares $390,870.00 -5.2%N/A6.5 $6.45
2/28/202063,900 shares $274,770.00 +47.2%N/A2.1 $4.30
2/14/202043,400 shares $298,592.00 +2.4%N/A1.3 $6.88
1/31/202042,400 shares $318,424.00 -1.6%N/A1.2 $7.51
1/15/202043,100 shares $322,388.00 +8.6%N/A1 $7.48
12/31/201939,700 shares $289,016.00 No ChangeN/A0.6 $7.28

IPHA Short Interest - Frequently Asked Questions

What is Innate Pharma's current short interest?

Short interest is the volume of Innate Pharma shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 58,800 shares of IPHA short. Learn More on Innate Pharma's current short interest.

What is a good short interest ratio for Innate Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IPHA shares currently have a short interest ratio of 7.0. Learn More on Innate Pharma's short interest ratio.

Is Innate Pharma's short interest increasing or decreasing?

Innate Pharma saw a decrease in short interest in October. As of October 15th, there was short interest totaling 58,800 shares, a decrease of 18.1% from the previous total of 71,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Innate Pharma's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Innate Pharma: Silence Therapeutics plc (1.12%), Aura Biosciences, Inc. (2.46%), Altimmune, Inc. (31.28%), Aquestive Therapeutics, Inc. (11.85%), Arcturus Therapeutics Holdings Inc. (17.92%), Sage Therapeutics, Inc. (12.15%), SIGA Technologies, Inc. (12.16%), Verve Therapeutics, Inc. (27.92%), KalVista Pharmaceuticals, Inc. (15.76%), PureTech Health plc (0.02%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Innate Pharma stock?

Short selling IPHA is an investing strategy that aims to generate trading profit from Innate Pharma as its price is falling. IPHA shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Innate Pharma?

A short squeeze for Innate Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IPHA, which in turn drives the price of the stock up even further.

How often is Innate Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPHA, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:IPHA) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners